Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 3Phase 2 1

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

OTHER 5NIH 2

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 3Genitourinary 2

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Recurrence 1Papilloma 1Healthy, no Evidence of Disease 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × 3,3'-diindolylmethane × Clear all
NCT02197000 2020-11-12

A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers

Rabin Medical Center

Phase NA Completed
23 enrolled
Breast

Breast Neoplasms

NCT00888654 2018-03-19

Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
41 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT01391689 2017-11-06

Diindolylmethane in Treating Patients With Breast Cancer

University of Arizona

Phase NA Completed
144 enrolled
Breast

Breast Neoplasms

NCT00591305 2017-05-18

New Therapy of Laryngeal Papilloma In Children

Boston University

Phase NA Terminated
1 enrolled 6 charts

Papilloma, Recurrence

NCT00784394 2016-12-29

Diindolylmethane in Preventing Cancer in Healthy Volunteers

National Cancer Institute (NCI)

Phase 1 Completed
20 enrolled

Healthy, no Evidence of Disease

NCT00450229 2015-12-04

Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
45 enrolled
Genitourinary

Prostatic Neoplasms

NCT01022333 2009-12-01

The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

Women's College Hospital

Phase 1 Unknown
300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡